EMA Paves the Way for a New Blood Cancer Immunotherapy for Children – Labiotech.eu (blog)
Labiotech.eu (blog) |
EMA Paves the Way for a New Blood Cancer Immunotherapy for Children
Labiotech.eu (blog) ATIR101 is a T-cell immunotherapy that eliminates alloreactive cells from the donor to minimize the risk of graft-versus-host disease (GVHD) in HSCT, currently the most effective treatment for most blood cancers. At the same time, ATIR101 contains … |
